awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37732287-1C8B072E-C6D9-495E-8EE9-B04A91814C79
Q37732287-1C8B072E-C6D9-495E-8EE9-B04A91814C79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37732287-1C8B072E-C6D9-495E-8EE9-B04A91814C79
Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC.
P2860
Q37732287-1C8B072E-C6D9-495E-8EE9-B04A91814C79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37732287-1C8B072E-C6D9-495E-8EE9-B04A91814C79
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4963d0f49fa1c899ac6771d8b4c2b2c95d788f4a
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).